CALIDI BIOTHERAPEUTICS, INC.

Profile

Company Names

CALIDI BIOTHERAPEUTICS, INC.

Addresses

4475 EXECUTIVE DRIVE, SUITE 200, SAN DIEGO, CA 92121

Phone Numbers

858-794-9600

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2021

State Incorporated:

DELAWARE

Total Amount Raised:

$10,287,088.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2024-06-03 
$5,549,588.00 
$5,549,588.00 
$0.00 
 
5
2024-03-08 
$3,500,000.00 
$3,500,000.00 
$0.00 
Debt 
4
2024-02-21 
$32,500.00 
$65,000.00 
$32,500.00 
Equity 
3
2024-01-26 
$1,000,000.00 
$1,000,000.00 
$0.00 
Debt 
2
2024-01-19 
$10,000.00 
$10,000.00 
$0.00 
Equity 
1
2023-11-01 
$195,000.00 
$341,250.00 
$146,250.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ALLAN 
 
CAMAISA 
EXECUTIVE OFFICER, DIRECTOR
CALIDI BIOTHERAPEUTICS, INC.   |  CALIDI BIOTHERAPEUTICS, INC.
ANDREW 
 
JACKSON 
EXECUTIVE OFFICER
ALTHEADX, INC.   |  RA MEDICAL SYSTEMS, INC.   |  452 TALF FUND, LP   |  ETERNA THERAPEUTICS INC.   |  CALIDI BIOTHERAPEUTICS, INC.
DAVID 
 
LAPRE 
DIRECTOR
CALIDI BIOTHERAPEUTICS, INC.
SCOTT 
 
LEFTWICH 
DIRECTOR
CALIDI BIOTHERAPEUTICS, INC.   |  CALIDI BIOTHERAPEUTICS, INC.
BORIS 
 
MINEV 
EXECUTIVE OFFICER
CALIDI BIOTHERAPEUTICS, INC.   |  CALIDI BIOTHERAPEUTICS, INC.
GEORGE 
 
NG 
DIRECTOR
MORPHOGENESIS INC   |  GGWP, INC.   |  CALIDI BIOTHERAPEUTICS, INC.   |  TUHURA BIOSCIENCES, INC.   |  CALIDI BIOTHERAPEUTICS, INC.   |  TUHURA BIOSCIENCES, INC./NV
WENDY 
 
PIZARRO 
EXECUTIVE OFFICER
CALIDI BIOTHERAPEUTICS, INC.   |  CALIDI BIOTHERAPEUTICS, INC.
JAMES 
A. 
SCHOENECK 
DIRECTOR
BRAINCELLS INC   |  FIBROGEN INC   |  CALIDI BIOTHERAPEUTICS, INC.
ALAN 
R. 
STEWART 
DIRECTOR
EPSILON SYSTEMS SOLUTIONS, INC.   |  RIPPLENAMI, INC.   |  NAVAL COATING, INC.   |  NCI HOLDINGS, INC.   |  CALIDI BIOTHERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-06-06
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2024-06-03 
2024-03-21
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2024-01-19 
2024-03-21
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2024-02-21 
2024-03-21
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2023-11-01 
2024-03-21
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2024-01-26 
2024-03-21
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2024-03-08 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LADENBURG THALMANN + CO. INC.
505